Welcome to LookChem.com Sign In|Join Free
  • or
4-Oxazolecarboxylicacid,2-ethynyl-,ethylester(9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

617705-26-7

Post Buying Request

617705-26-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

617705-26-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 617705-26-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,1,7,7,0 and 5 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 617705-26:
(8*6)+(7*1)+(6*7)+(5*7)+(4*0)+(3*5)+(2*2)+(1*6)=157
157 % 10 = 7
So 617705-26-7 is a valid CAS Registry Number.

617705-26-7Relevant academic research and scientific papers

Streamlined Symmetrical Total Synthesis of Disorazole B1and Design, Synthesis, and Biological Investigation of Disorazole Analogues

Aujay, Monette,Dherange, Balu D.,Gavrilyuk, Julia,Gu, Christine,Krieger, Johannes,Lin, Baiwei,Munneke, Stefan,Murhade, Ganesh M.,Nicolaou, K. C.,Purcell, James W.,Sandoval, Joseph,Sarvaiaya, Hetal,Subramanian, Parthasarathi,Vourloumis, Dionisios,Zhang, Zhaomei

, p. 15476 - 15487 (2020/10/02)

Taking advantage of the C2-symmetry of the antitumor naturally occurring disorazole B1 molecule, a symmetrical total synthesis was devised with a monomeric advanced intermediate as the key building block, whose three-step conversion to the natural product

SYNTHESIS OF DISORAZOLES AND ANALOGS THEREOF AS POTENT ANTICANCER AGENTS

-

, (2019/01/11)

In one aspect, the present disclosure provides disorazole analogs of the formula: Formula (I) wherein the variables are as defined herein. In another aspect, the present disclosure also provides methods of preparing the compounds disclosed herein. In another aspect, the present disclosure also provides pharmaceutical compositions and methods of use of the compounds disclosed herein. Additionally, drug conjugates with cell targeting moieties of the compounds are also provided.

Synthetic studies toward the disorazoles: Synthesis of a masked northern half of disorazole D1 and a cyclopropane analog of the masked northern half of disorazole A1

Haustedt, Lars Ole,Panicker, Sreeletha B.,Kleinert, Mike,Hartung, Ingo V.,Eggert, Ulrike,Niess, Barbara,Hoffmann

, p. 6967 - 6977 (2007/10/03)

The synthesis of a masked northern half of the natural product disorazole D1 and a cyclopropane analog of the masked northern half of disorazole A1 is described. The synthesis involves in both cases as key steps a Z-selective Wittig olefination and a Sonogashira cross-coupling reaction.

Toward the total synthesis of disorazole A1: Asymmetric synthesis of the masked northern half

Hartung, Ingo V.,Eggert, Ulrike,Haustedt, Lars Ole,Niess, Barbara,Schaefer, Peter M.,Hoffmann, H. Martin R.

, p. 1844 - 1850 (2007/10/03)

The stereoselective synthesis of the masked northern half of the antimitotic natural product disorazole A1 is described involving as key step a Z-selective Wittig olefination of a C1-C11 epoxy aldehyde with a C12-C19 phosphonium iodide.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 617705-26-7